A General Model of Prion Strains and Their Pathogenicity

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Science

• Publication date

  2007-11-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/SCIENCE.1138718PMID 17991853
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice.

  2007cited by this paper
• Neurology®

  2007cited by this paper
• Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

  2007cited by this paper
• Kuru in the 21st century--an acquired human prion disease with very long incubation periods.

  2006cited by this paper
• Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host

  2006cited by this paper
• Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report.

  2006cited by this paper
• The physical basis of how prion conformations determine strain phenotypes

  2006cited by this paper
• Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease.

  2005cited by this paper
• Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie

  2005cited by this paper
• Immunopathology and Infectious Diseases Detection of Type 1 Prion Protein in Variant Creutzfeldt-Jakob Disease

  2005cited by this paper
• Structural insights into a yeast prion illuminate nucleation and strain diversity

  2005cited by this paper
• Strain-specific morphologies of yeast prion amyloid fibrils.

  2005cited by this paper
• In vitro generation of infectious scrapie prions.

  2005cited by this paper
• Anchorless Prion Protein Results in Infectious Amyloid Disease Without Clinical Scrapie

  2005cited by this paper
• Immunodetection of disease‐associated mutant PrP, which accelerates disease in GSS transgenic mice

  2005cited by this paper
• IL-13受体α2降低血吸虫病肉芽肿的炎症反应并延长宿主存活时间[英]/Mentink-Kane MM,Cheever AW，Thompson RW，et al//Proc Natl Acad Sci U S A

  2005cited by this paper
• Mechanism of cross-species prion transmission: an infectious conformation compatible with two highly divergent yeast prion proteins.

  2005cited by this paper
• Prion generation in vitro: amyloid of Ure2p is infectious

  2005cited by this paper
• PrP glycoforms are associated in a strain-specific ratio in native PrPSc.

  2005cited by this paper
• Human Prion Protein with Valine 129 Prevents Expression of Variant CJD Phenotype

  2004cited by this paper
• Synthetic Mammalian Prions

  2004cited by this paper
• The Residue 129 Polymorphism in Human Prion Protein Does Not Confer Susceptibility to Creutzfeldt-Jakob Disease by Altering the Structure or Global Stability of PrPC*

  2004cited by this paper
• Protein-only transmission of three yeast prion strains

  2004cited by this paper
• Prion genetics: new rules for a new kind of gene.

  2004cited by this paper
• Conformational variations in an infectious protein determine prion strain differences

  2004cited by this paper
• Characterization of two distinct prion strains derived from bovine spongiform encephalopathy transmissions to inbred mice.

  2004cited by this paper
• Cross-Linking Cellular Prion Protein Triggers Neuronal Apoptosis in Vivo

  2004cited by this paper
• Balancing Selection at the Prion Protein Gene Consistent with Prehistoric Kurulike Epidemics

  2003cited by this paper
• Subclinical prion infection.

  2003cited by this paper
• Caspase‐12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein

  2003cited by this paper
• Depleting Neuronal PrP in Prion Infection Prevents Disease and Reverses Spongiosis

  2003cited by this paper
• Post‐natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration

  2002cited by this paper
• BSE prions propagate as either variant CJD‐like or sporadic CJD‐like prion strains in transgenic mice expressing human prion protein

  2002cited by this paper
• Neurotoxicity and Neurodegeneration When PrP Accumulates in the Cytosol

  2002cited by this paper
• Long-Term Subclinical Carrier State Precedes Scrapie Replication and Adaptation in a Resistant Species: Analogies to Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease in Humans

  2001cited by this paper
• Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay.

  2001cited by this paper
• Three-dimensional structures of prion proteins.

  2001cited by this paper
• Prion diseases of humans and animals: their causes and molecular basis.

  2001cited by this paper
• Species-barrier-independent prion replication in apparently resistant species.

  2000cited by this paper
• Quantitative traits of prion strains are enciphered in the conformation of the prion protein.

  2000cited by this paper
• Differences in Proteinase K Resistance and Neuronal Deposition of Abnormal Prion Proteins Characterize Bovine Spongiform Encephalopathy (BSE) and Scrapie Strains

  1999cited by this paper
• Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples.

  1999cited by this paper
• Strain-specific prion-protein conformation determined by metal ions

  1999cited by this paper
• Variant Creutzfeldt-Jakob disease.

  1999cited by this paper
• Fatal familial insomnia

  1998cited by this paper
• Eight prion strains have PrPSc molecules with different conformations

  1998cited by this paper
• Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease.

  1998cited by this paper
• A transmembrane form of the prion protein in neurodegenerative disease.

  1998cited by this paper
• Observations on thermostable subpopulations of the unconventional agents that cause transmissible degenerative encephalopathies.

  1998cited by this paper
• Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent

  1997cited by this paper
• The same prion strain causes vCJD and BSE

  1997cited by this paper
• Transmission of the BSE Agent to Mice in the Absence of Detectable Abnormal Prion Protein

  1997cited by this paper
• Prion protein (PrP) with amino‐proximal deletions restoring susceptibility of PrP knockout mice to scrapie.

  1996cited by this paper
• Molecular basis of phenotypic variability in sporadc creudeldt‐jakob disease

  1996cited by this paper
• Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice.

  1996cited by this paper
• Evidence for the Conformation of the Pathologic Isoform of the Prion Protein Enciphering and Propagating Prion Diversity

  1996cited by this paper
• Normal host prion protein necessary for scrapie-induced neurotoxicity

  1996cited by this paper
• Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD

  1996cited by this paper
• Prion diseases of humans and animals

  1996cited by this paper
• Non-genetic propagation of strain-specific properties of scrapie prion protein

  1995cited by this paper
• Unaltered susceptibility to BSE in transgenic mice expressing human prion protein

  1995cited by this paper
• Transmission of fatal familial insomnia to laboratory animals.

  1995cited by this paper
• Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins.

  1994cited by this paper
• No propagation of prions in mice devoid of PrP

  1994cited by this paper
• Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy

  1994cited by this paper
• Cell-free formation of protease-resistant prion protein

  1994cited by this paper
• PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology.

  1994cited by this paper
• No propagation of prions in mice devoid of PrP.

  1994cited by this paper
• A kinetic model for amyloid formation in the prion diseases: importance of seeding.

  1993cited by this paper
• Mice devoid of PrP are resistant to scrapie.

  1993cited by this paper
• Scrapie strain variation and mutation.

  1993cited by this paper
• Neurotoxicity of a prion protein fragment

  1993cited by this paper
• Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

  1993cited by this paper
• Transmission of bovine spongiform encephalopathy and scrapie to mice.

  1992cited by this paper
• Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein

  1992cited by this paper
• Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent

  1992cited by this paper
• Fatal familial insomnia

  1992cited by this paper
• Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease.

  1991cited by this paper
• Homozygous prion protein genotype predisposes to sporadic Creutzfeldt–Jakob disease

  1991cited by this paper
• Homozygous prion protein genotype predisposes to sporadic Creutzfeldt–Jakob disease

  1991cited by this paper
• Spontaneous neurodegeneration in transgenic mice with mutant prion protein

  1990cited by this paper
• Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication.

  1990cited by this paper
• Transmissible and non-transmissible amyloidoses: autocatalytic post-translational conversion of host precursor proteins to β-pleated sheet configurations

  1988cited by this paper
• Transmissible and non-transmissible amyloidoses: autocatalytic post-translational conversion of host precursor proteins to beta-pleated sheet configurations.

  1988cited by this paper
• Novel proteinaceous infectious particles cause scrapie.

  1982cited by this paper
• Evidence that the transmission of one source of scrapie agent to hamsters involves separation of agent strains from a mixture.

  1978cited by this paper
• Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation.

  1973cited by this paper
• SLOW, LATENT AND TEMPERATE VIRUS INFECTIONS

  1967cited by this paper
• Slow, Latent, and Temperate Virus Infections

  1967cited by this paper
• SLOW, LATENT, AND TEMPERATE VIRUS INFECTIONS. NINDB MONOGRAPH No. 2

  1967cited by this paper
• Nature of the Scrapie Agent: Self-replication and Scrapie

  1967cited by this paper
• Self-replication and scrapie.

  1967cited by this paper

• D178N prion protein mutation endows RML prions with new strain properties that do not mimic human genetic prion diseases

  2026cites this paper
• Characterisation of the PRNP gene polymorphisms in Zom sheep

  2026cites this paper
• Strain Traits of Intracranially Administered L‐Type Bovine Spongiform Encephalopathy Prions Are not Significantly Modified During Intraspecies Transmission in Cynomolgus Monkeys

  2026cites this paper
• Seed amplification of MSA alpha-synuclein aggregates preserves the biological and structural properties of brain-derived aggregates

  2025cites this paper
• Phylogeny and Molecular Characterisation of PRNP in Red-Tailed Phascogale (Phascogale calura)

  2025cites this paper
• Enhanced lysosomal activity prevents infection with PrPSc and the seeding activity of α-synuclein & tau prions

  2025cites this paper
• Microbial Composition, Disease Trajectory and Genetic Background in a Slow Onset Model of Frontotemporal Lobar Degeneration

  2025cites this paper
• Reactive Microglia and Astrocytes as Therapeutic Targets in Prion Diseases.

  2025cites this paper
• Mutations in Hsp40 co-chaperone change the unique canonical inter-domain interactions stimulating LGMDD1 myopathy

  2025cites this paper
• Sporadic Creutzfeldt-Jakob Disease Complicated by Intracerebral Hemorrhaging in the Early Stage of Onset

  2025cites this paper
• Canadian 2021 H-type Bovine Spongiform Encephalopathy case associated with a novel E211K polymorphism in prion protein gene

  2025cites this paper
• International Journal of Food and Nutritional Sciences

  2025cites this paper
• Overview of North American Isolates of Chronic Wasting Disease Used for Strain Research

  2025cites this paper
• Targeting the Cellular Prion Protein as a Biomarker for Stem Cells, Cancer, and Regeneration

  2025cites this paper
• Intracellular trafficking SNARE protein, syntaxin-6, modifies prion cellular phenotypes and risk of disease development in vivo

  2025cites this paper
• The Phenotypic Spectrum of Sporadic Creutzfeldt-Jakob Disease Cortical Subtype.

  2025cites this paper
• Space–time distribution of classical scrapie in Italian sheep: assessing the effectiveness of the National Genetic Selection Plan

  2025cites this paper
• Prions and protein aggregates as pathogens, self-propagating structures, biomarkers, and therapeutic targets

  2025cites this paper
• Effect of primary structural variation on cervid prion protein in flexibility, stability, and spontaneous misfolding propensity.

  2025cites this paper
• Classical BSE emergence from Nor98/atypical scrapie: Unraveling the shift vs. selection dichotomy in the prion field

  2025cites this paper
• Modeling Protein Aggregation Kinetics from NMR Data.

  2025cites this paper
• Conservation of strain properties of bank vole-adapted chronic wasting disease in the absence of glycosylation and membrane anchoring

  2025cites this paper
• Amyloid Cross-Interactions through the Lens of Simulations: The Case of Aβ–IAPP

  2025cites this paper
• Exploring Protein Misfolding and Aggregate Pathology in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Interventions

  2025cites this paper
• Inducers and modulators of protein aggregation in Alzheimer's disease - Critical tools for understanding the foundations of aggregate structures

  2025cites this paper
• Cofactors facilitate bona fide prion misfolding in vitro but are not necessary for the infectivity of recombinant murine prions

  2025cites this paper
• Molecular Insights into Prion Degradation in Creutzfeldt Jakob Disease’s Challenges and Future Directions: A Review

  2025cites this paper
• Mutations in Hsp40 co-chaperone change the canonical interdomain interactions stimulating LGMDD1 myopathy

  2025cites this paper
• How is the Amyloid Fold Built? Polymorphism and the Microscopic Mechanisms of Fibril Assembly.

  2025cites this paper
• NIR Light-Triggered Structural Modulation of Self-Assembled Prion Protein Aggregates.

  2025cites this paper
• Breaking the Mould: How the First Structure of a Deer Prion Suggests the Framework for Interspecies Strain Diversity and Transmission Barriers

  2025cites this paper
• Hidden faces of alpha-synuclein: Cryo-EM revelation of fibril polymorphs driven by disease, mutations, and PTMs

  2025cites this paper
• The Transthyretin Protein and Amyloidosis – an Extraordinary Chemical Biology Platform

  2024cites this paper
• α-Synuclein Strain Propagation is Independent of Cellular Prion Protein Expression in Transgenic Mice

  2024cites this paper
• A Story Between s and S: [Het-s] Prion of the Fungus Podospora anserina

  2024cites this paper
• New implications for prion diseases therapy and prophylaxis

  2024cites this paper
• Atomic force microscopy 3D structural reconstruction of individual particles in the study of amyloid protein assemblies.

  2024cites this paper
• α-Synuclein seed amplification technology for Parkinson's disease and related synucleinopathies.

  2024cites this paper
• Assessment of the zoonotic potential of atypical scrapie prions in humanized mice reveals rare phenotypic convergence but not identity with sporadic CJD prions.

  2024cites this paper
• Change in the molecular properties of CH1641 prions after transmission to wild‐type mice: Evidence for a single strain

  2024cites this paper
• Strain-Specific Targeting and Destruction of Cells by Prions

  2024cites this paper
• The molecular determinants of a universal prion acceptor

  2024cites this paper
• Iatrogenic Alzheimer’s disease in recipients of cadaveric pituitary-derived growth hormone

  2024cites this paper
• The dynamics of prion spreading is governed by the interplay between the non-linearities of tissue response and replication kinetics

  2024cites this paper
• A-synuclein prion strains differentially adapt after passage in mice

  2024cites this paper
• Species barrier as molecular basis for adaptation of synthetic prions with N‐terminally truncated PrP

  2024cites this paper
• The Brain Interactome of a Permissive Prion Replication Substrate

  2024cites this paper
• Multiple aspects of amyloid dynamics in vivo integrate to establish prion variant dominance in yeast

  2024cites this paper
• Effect of host and strain factors on α-synuclein prion pathogenesis.

  2024cites this paper
• Minor prion substrains overcome transmission barriers

  2024cites this paper
• Prions: structure, function, evolution, and disease

  2024cites this paper
• Lack of prion transmission barrier in human PrP transgenic Drosophila

  2024cites this paper
• Lack of Evidence for Transmission of Atypical H‐Type Bovine Spongiform Encephalopathy Prions (H‐BSE Prions) by Intracranial and Oral Challenges to Nonhuman Primates

  2024cites this paper
• α-Synuclein strain propagation is independent of cellular prion protein expression in a transgenic synucleinopathy mouse model

  2024cites this paper
• Unravelling the Mysteries of Prions: Insights into the Biochemistry, Pathology and Therapeutics of Devastating Protein Misfolding Diseases

  2024influential citation
• Extraneural infection route restricts prion conformational variability and attenuates the impact of quaternary structure on infectivity

  2024cites this paper
• Post-translational modifications in prion diseases

  2024cites this paper
• Frontotemporal dementia-like disease progression elicited by seeded aggregation and spread of FUS

  2024cites this paper
• Characterisation of European Field Goat Prion Isolates in Ovine PrP Overexpressing Transgenic Mice (Tgshp IX) Reveals Distinct Prion Strains

  2024influential citation
• Genetic characterization of the prion protein gene in camels (Camelus) with comments on the evolutionary history of prion disease in Cetartiodactyla

  2024cites this paper
• Propagation of distinct CWD prion strains during peripheral and intracerebral challenges of gene-targeted mice

  2024cites this paper
• Chronic Wasting Disease: State of the Science

  2024cites this paper
• Mouse α-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases

  2024cites this paper
• Syntaxin-6 delays prion protein fibril formation and prolongs the presence of toxic aggregation intermediates

  2023cites this paper
• Spatial risk assessment of ovine Scrapie in Brazil

  2023cites this paper
• Multiple steps of prion strain adaptation to a new host

  2023influential citation
• Inter- and intra-species conversion efficacies of Norwegian prion isolates estimated by serial protein misfolding cyclic amplification

  2023cites this paper
• Strain‐dependent role of copper in prion disease through binding to histidine residues in the N‐terminal domain of prion protein

  2023cites this paper
• Pathologic polyglutamine aggregation begins with a self-poisoning polymer crystal

  2023cites this paper
• Evidence for preexisting prion substrain diversity in a biologically cloned prion strain

  2023cites this paper
• Heterogeneity of pathological prion protein accumulation in the brain of moose (Alces alces) from Norway, Sweden and Finland with chronic wasting disease

  2023cites this paper
• Development of a methodology for large-scale production of prions for biological and structural studies

  2023cites this paper
• Genetic modulation of CWD prion propagation in cervid PrP Drosophila

  2023cites this paper
• Are fibrinaloid microclots a cause of autoimmunity in Long Covid and other post-infection diseases?

  2023cites this paper
• Propagation of PrPSc in mice reveals impact of aggregate composition on prion disease pathogenesis

  2023cites this paper
• In silico investigation of the structural stability as the origin of the pathogenicity of α-synuclein protofibrils

  2023cites this paper
• Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion disease

  2023cites this paper
• Oral vaccination as a potential strategy to manage chronic wasting disease in wild cervid populations

  2023cites this paper
• Pathologic polyglutamine aggregation begins with a self-poisoning polymer crystal

  2023cites this paper
• New developments in prion disease research using genetically modified mouse models

  2023influential citation
• Human prion disease: molecular pathogenesis, and possible therapeutic targets and strategies

  2023cites this paper
• Two structurally defined Aβ polymorphs promote different pathological changes in susceptible mice

  2023cites this paper
• The smallest infectious substructure encoding the prion strain structural determinant revealed by spontaneous dissociation of misfolded prion protein assemblies

  2023cites this paper
• Intranasally delivered mesenchymal stromal cells decrease glial inflammation early in prion disease

  2023cites this paper
• Beyond Strains: Molecular Diversity in Alpha-Synuclein at the Center of Disease Heterogeneity

  2023cites this paper
• Reactive astrocytes associated with prion disease impair the blood brain barrier

  2023cites this paper
• Thiophene‐Based Ligands: Design, Synthesis and Their Utilization for Optical Assignment of Polymorphic‐Disease‐Associated Protein Aggregates

  2023cites this paper
• Pathogenicity, strain properties and interspecies transmission capacity of pure recombinant prion protein assemblies

  2023cites this paper
• New developments in prion disease research

  2023cites this paper
• The seeding barrier between human and Syrian hamster prion protein amyloid fibrils is determined by β2-α2 loop sequence elements.

  2023cites this paper
• Recombinant ovine prion protein can be mutated at position 136 to improve its efficacy as an inhibitor of prion propagation

  2023cites this paper
• Loss of residues 119 - 136, including the first β-strand of human prion protein, generates an aggregation-competent partially "open" form.

  2023cites this paper
• Alanine replacements in the structured C-terminal domain of the prion protein reveal conformationally variable regions as major determinants for prion propagation

  2023cites this paper
• Experimental transmission of ovine atypical scrapie to cattle

  2023cites this paper
• Vaccines for prion diseases: a realistic goal?

  2023cites this paper
• α-Synuclein Conformational Strains as Drivers of Phenotypic Heterogeneity in Neurodegenerative Diseases.

  2023cites this paper
• Conformational diversity in purified prions produced in vitro

  2023cites this paper
• Clinical considerations in early-onset cerebral amyloid angiopathy

  2023cites this paper
• The Zoonotic Potential of Chronic Wasting Disease—A Review

  2023cites this paper
• PMCA screening of retropharyngeal lymph nodes in white-tailed deer and comparisons with ELISA and IHC

  2023cites this paper